First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset*Miyako Satouchi, Katsuyuki Hotta, Keisuke Aoe et al.|Cancer Science|2021Cited by 18
A Phase II, Open Label, Single-Arm Study on the Efficacy of Cabozantinib in Patients With Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring MET Exon 14 Alterations who Developed Acquired Resistance to Tepotinib or Capmatinib (CAPTURE Trial)Masayuki Takeda, Mototsugu Shimokawa, Masahide Ota et al.|Clinical Lung Cancer|2024Cited by 5